Coronavirus: Weak Point of Remdesivir
Date Time Coronavirus: Weak Point of Remdesivir The drug Remdesivir only weakly inhibits the new coronavirus SARS-CoV-2. Research groups from Göttingen and Würzburg have discovered why this is so. The Covid-19 drug Remdesivir (purple) is incorporated into the new RNA chain during the copying process and suppresses the duplication of the coronavirus genome. (Image: Hauke Hillen, Goran Kokic, Patrick Cramer / Max-Planck-Institut für biophysikalische Chemie Göttingen) Remdesivir is the first drug against Covid-19 to be conditionally approved in Europe and the United States. The drug is desi...
Source: miragenews.com